Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 31.91

+1.9%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Douglas who wrote (205)	7/22/1997 10:57:00 AM
From: Joel	of 455

A better play in small biotechnology is Cypress Biosciences (CYPB). Paramount capital is involved and providing the necessary ingriedents to make this one successful. It is up from 1 7/16 to 2 7/16 in a relatively short period of time. Yesterday they received yet another patent. They are in trials for an already FDA approved drug for blood disorders. The PROSORBA COLUMN is being tested for RA. I have a feeling that the people you mentioned that have been reassigned are working with CYPB. Take a look and let me know if you agree.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next